News

A coalition of leukemia researchers led by scientists from UC San Francisco has discovered surprising genetic diversity in juvenile myelomonocytic leukemia (JMML), a rare but aggressive childhood blood cancer.

Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.

Company has announced Zhen Pang as scientific director.

Company’s second office in the region will strengthen customer relations and help develop new business among emerging and established Japanese companies.

Scientists at the University of British Columbia, Vancouver Coastal Health and the BC Cancer Agency have discovered a protein from malaria that could one day help stop cancer in its tracks.

Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.

Mouse study suggests genomic screening before treatment may help prevent anemia.

Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.

Computational models suggest new design for nanoparticles used in targeted drug delivery.

Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.